[1]谢乃容 赵薇 秦明照.缺血伴非阻塞性冠状动脉疾病研究进展[J].心血管病学进展,2019,(8):1134-1138.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.017]
　XIE NairongZHAO WeiQIN Mingzhao.Ischemia with No Obstructive Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2019,(8):1134-1138.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.017]
点击复制

缺血伴非阻塞性冠状动脉疾病研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年8期
页码:
1134-1138
栏目:
出版日期:
2019-11-25

文章信息/Info

Title:
Ischemia with No Obstructive Coronary Artery Disease
作者:
谢乃容 赵薇 秦明照
(首都医科大学附属北京同仁医院老年医学科/干部医疗科,北京 100730)
Author(s):
XIE NairongZHAO WeiQIN Mingzhao
(Department of Geriatrics,Beijing Tong Ren Hospital,Capital Medical University,Beijing 100730,China)
关键词:
非阻塞性冠状动脉疾病; 心肌缺血; 微血管功能障碍
Keywords:
No obstructive coronary artery disease;  Myocardial ischemia;  Microvascular dysfunction
DOI:
10.16806/j.cnki.issn.1004-3934.2019.08.017
摘要:
缺血伴非阻塞性冠状动脉疾病（INOCA）指患者出现明显的心肌缺血表现，但冠状动脉造影显示冠状动脉正常或接近正常（狭窄＜50%）的冠状动脉疾病。不同的研究中INOCA的患病率差异很大，其发病原因种类多，可单独或联合起作用。近年来，微血管功能障碍如微血管痉挛、血管舒张障碍越来越受到人们的关注。INOCA的其他相对常见病因还有冠状动脉斑块、冠状动脉夹层、冠状动脉微血管痉挛、应激性心肌病等。INOCA的研究目的在于从众多发病原因中明确诊断，针对病因进行治疗，从而提高患者的生存率和生存质量。
Abstract:
Ischemia with no obstructive coronary artery disease (INOCA) is a clinical syndrome characterized by evidence of ischemia with normal or near normal coronary arteries on angiography (stenosis severity＜50%).Prevalence rates vary widely among different studies. The Mechanisms contributing to INOCA appear multifactorial and may operate alone or in combination. Over the years,there has been increasing recognition of the role of microvascular dysfunction such as microvasospasm and vasodilation disorder. Other common causes are coronary plaque,coronary artery dissection,coronary microvasospasm,Takotsubo cardiomyopathy,and so on. The research of INOCA aims at how to make a clear diagnosis for patients among various pathogenic causes,so as to implement correct etiological treatment for patients and improve the survival rate and life quality of patients

参考文献/References:

[1].Bairey Merz CN,Pepine CJ,Walsh MN,et al. Ischemia and no obstructive coronary artery disease (INOCA) :developing evidence-based therapies and research agenda for the next decade[J]. Circulation,2017,135(11):1075-1092.
[2].Herscovici R,Sedlak T,Wei J,et al. Ischemia and no obstructive coronary artery disease ( INOCA ) :what is the risk? [J].J Am Heart Assoc,2018,7(17):e008868.
[3].Thygesen K,Alpert JS,Jaffe AS,et al. Third universal definition of myocardial infarction[J]. Circulation,2012,126(16):2020-2035.
[4].Agewall S,Beltrame JF,Reynolds HR,et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries[J]. Eur Heart J,2017,38(3):143-153.
[5].Lee BK,Lim HS,Fearon WF,et al. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease[J]. Circulation,2015,131(12):1054-1060.
[6].van Rosendael AR,Kroft LJ,Broersen A,et al. Relation between quantitative coronary CTA and myocardial ischemia by adenosine stress myocardial CT perfusion[J]. J Nucl Cardiol,2017,24(4):1253-1262
[7].Shaw LJ,Shaw RE,Merz CN,et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry[J]. Circulation,2008,117(14):1787-1801.
[8].Jespersen L,Hvelplund A,Abildstrom SZ,et al.Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events[J]. Eur Heart J,2012,33(6):734-744.
[9].Pasupathy S,Air T,Dreyer RP,et al. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries[J]. Circulation,2015,131(10):861-870.
[10].Safdar B,Spatz ES,Dreyer RP,et al. Presentation,clinical profile,and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA):results from the VIRGO study[J]. J Am Heart Assoc,2018,7:e009174.
[11].Pepine CJ,Ferdinand KC,Shaw LJ,et al. Emergence of nonobstructive coronary artery disease:a woman’s problem and need for change in definition on angiography[J]. J Am Coll Cardiol,2015,66(17):1918-1933.
[12].Kothawade K,Bairey Merz CN. Microvascular coronary dysfunction in women:pathophysiology,diagnosis,and management[J]. Curr Probl Cardiol,2011,36(8):291-318.
[13].Tornvall P,Gerbaud E,Behaghel A,et al. Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease:a meta-analysis of individual patient data[J]. Atherosclerosis,2015,241(1):87-91.
[14].Reynolds HR,Srichai MB,Iqbal SN,et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease[J]. Circulation,2011,124(13):1414-1425.
[15].Feuchtner GM,Barbieri F,Langer C,et al. Non obstructive high-risk plaque but not calcified by coronary CTA,and the G-score predict ischemia[J]. J Cardiovasc Comput Tomogr,2019, pii:S1934-5925(18)30397-6.
[16].Ferrante G,Nakano M,Prati F,et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes:a clinicopathological study[J]. Circulation,2010, 122(24):2505-2513.
[17].Iqbal SN,Feit F,Mancini GB,et al. Characteristics of plaque disruption by intravascular ultrasound in women presenting with myocardial infarction without obstructive coronary artery disease[J]. Am Heart J,2014,167(5),715-722.
[18].Raffel OC,Merchant FM,Tearney GJ,et al. In vivo association between positive coronary artery remodelling and coronary plaque characteristics assessed by intravascular optical coherence tomography[J]. Eur Heart J,2008, 29 (14):1721-1728.
[19].Lanza GA,Careri G,Crea F. Mechanisms of coronary artery spasm[J]. Circulation,2011,124(16):1774-1782.
[20].Scalone G,Niccoli G,Crea F. Pathophysiology,diagnosis and management of MINOCA:an update[J]. Eur Heart J Acute Cardiovasc Care,2019,8(1):54-62.
[21].Hung MJ,Hu P,Hung MY. Coronary artery spasm:review and update[J]. Int J Med Sci,2014,11(11):1161-1171.
[22].Montone RA,Niccoli G,Fracassi F,et al. Patients with acute myocardial infarction and nonobstructive coronary arteries:safety and prognostic relevance of invasive coronary provocative tests[J]. Eur Heart J, 2018 ,39(2):91-98.
[23].Cenko E,Bergami M,Varotti E,et al. Vasospastic angina and its relationship with the coronary microcirculation[J]. Curr Pharm Des,2018,24(25):2906-2910.
[24].Lanza GA,Sestito A,Sgueglia GA,et al. Current clinical features,diagnostic assessment and prognostic determinants of patients with variant angina[J]. Int J Cardiol,2007,118(1):41-47.
[25].Yip A,Saw J. Spontaneous coronary artery dissection—A review[J]. Cardiovasc Diagn Ther, 2015 ,5(1):37-48.
[26].Mahmoud AN,Taduru SS,Mentias A,et al. Trends of incidence,clinical presentation,and in-hospital mortality among women with acute myocardial infarction with or without spontaneous coronary artery dissection:a population-based analysis[J]. JACC Cardiovasc Interv,2018,11(1):80-90.
[27].Alfonso F,Paulo M,Dutary J. Endovascular imaging of angiographically invisible spontaneous coronary artery dissection[J]. JACC Cardiovasc Interv,2012,5(4):452-453
[28].Dawson DK. Acute stress-induced (Takotsubo) cardiomyopathy[J]. Heart,2018,104(2):96-102.
[29].Medeiros K,O’Connor MJ,Baicu CF,et al. Systolic and diastolic mechanics in stress cardiomyopathy[J]. Circulation,2014,129(16):1659-1667.
[30].Chow LTC,Chow M. Coronary artery myointimal dysplasia in patients with pheochromocytoma-possible causal relationship:pathophysiology and clinical implication with reference to Takotsubo cardiomyopathy and spontaneous coronary dissection[J]. Cardiovasc Pathol,2018,37:45-53.
[31].Kato K,Lyon AR,Ghadri JR,et al. Takotsubo syndrome:aetiology,presentation and treatment[J]. Heart,2017,103(18):1461-1469.
[32].Pacheco Claudio C,Quesada O,Pepine CJ,et al. Why names matter for women:MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease)[J]. Clin Cardiol,2018,41(2):185-193.
[33].Sara JD,Widmer RJ,Matsuzawa Y,et al.Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease[J]. JACC Cardiovasc Interv 2015,8(11):1445-1453.
[34].Kaski JC,Crea F,Gersh BJ,et al.Reappraisal of ischemic heart disease[J]. Circulation,2018,138(14):1463-1480.
[35].Bravo PE,di Carli MF,Dorbala S,et al. Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies[J]. Heart Fail Rev,2017,22(4):455-464.
[36].Ford?TJ,Corcoran D,Berry C. Stable coronary syndromes:pathophysiology,diagnostic advances and therapeutic?need[J]. Heart,2018,104(4):284-292.
[37].黄玉雪,常静. 冠状动脉微血管功能障碍诊治新进展[J]. 心血管病学进展,2018,39(4):594-598.
[38].Maddox TM,Stanislawski MA,Grunwald GK,et al. Nonobstructive coronary artery disease and risk of myocardial infarction[J]. JAMA 2014,312(17):1754-1763.
[39].Tamis-Holland JE,Jneid H,Reynolds HR,et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease:a scientific statement from the American Heart Association[J]. Circulation,2019,139(18):e891-e908.

相似文献/References:

[1]田丁,张俊峰.心肌缺血早期诊断的无创检查方法进展[J].心血管病学进展,2016,(1):19.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.006]
　TIAN Ding,ZHANG Junfeng.Review of Noninvasive Screening Methods Development in Early Diagnosis of Myocardial Ischemia[J].Advances in Cardiovascular Diseases,2016,(8):19.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.006]
[2]麦兆康 周滔.冠状动脉内心电图的临床应用研究进展[J].心血管病学进展,2020,(8):817.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.009]
　MAI ZhaokangZHOU Tao.Clinical Application of Intracoronary Electrocardiogram[J].Advances in Cardiovascular Diseases,2020,(8):817.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.009]
[3]马兴鸿 汪蕾 方纬.核素心肌显像在冠状动脉慢性完全闭塞临床诊疗中的应用价值[J].心血管病学进展,2022,(4):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
　MA Xinghong,WANG Lei,FANG Wei.Application Value of Radionuclide Myocardial Imaging In the Clinical Diagnosis And Treatment of Coronary Chronic Total Occlusion[J].Advances in Cardiovascular Diseases,2022,(8):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
[4]于筱斋?高艳香?郭紫玉?陈西霞?叶子翔?郑金刚.非阻塞性冠状动脉疾病的冠状动脉微循环功能障碍治疗新进展[J].心血管病学进展,2022,(5):385.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.001]
　YU Xiaozhai,GAO Yanxiang,GUO Ziyu,et al.Treatment of Coronary Microvascular Dysfunction in Non-Obstructive Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2022,(8):385.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.001]
[5]杨双 唐艳红.P2X3受体在心血管疾病中的研究进展[J].心血管病学进展,2022,(2):117.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.006]
　YANG Shuang,TANG Yanhong.P2X3 Receptor in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2022,(8):117.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.006]

更新日期/Last Update: 2020-01-20